title: Corrigendum to "Preclinical studies on new proteins as carrier for glycoconjugate vaccines" [Vaccine 34 (2016) 4235-4242].
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Tontini
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: M R
authors.initials: MR
authors.lastname: Romano
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Proietti
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Balducci
authors.affiliation: GSK Vaccines Institute for Global Health (GVGH) S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Micoli
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Balocchi
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Santini
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Masignani
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Berti
authors.affiliation: GK Vaccines S.r.l., Via Fiorentina 1, 53100 Siena, Italy. Electronic address: paolo.x.costantino@gsk.com.
authors.forename: P
authors.initials: P
authors.lastname: Costantino